TickerFacts.

Heartflow, Inc. (HTFL): Revenue

Annual figures by period end, from SEC filings.

$176.03M
Year ended 2025-12-31
$212.07M
Trailing 12 months to 2026-06-30
2023-12-31: $87.17M2024-12-31: $125.81M2025-12-31: $176.03M$176.03M
2023-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$176.03M+39.9%2026-03-18, From 2025-01-01
2024-12-31$125.81M+44.3%2026-03-18, From 2024-01-01
2023-12-31$87.17Mn/a2026-03-18, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Heartflow, Inc. (HTFL)2025-12-31$176.03M+39.9%
SI-BONE, Inc. (SIBN)2025-12-31$200.93M+20.2%
Neuronetics, Inc. (STIM)2025-12-31$149.16M+99.2%
Treace Medical Concepts, Inc. (TMCI)2025-12-31$212.69M+1.6%
InfuSystem Holdings, Inc (INFU)2025-12-31$143.44M+6.4%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$133.93M+14.2%
Cerus Corp (CERS)2025-12-31$233.80M+16.1%
Orthopediatrics Corp (KIDS)2025-12-31$236.35M+15.4%
Lemaitre Vascular Inc (LMAT)2025-12-31$249.60M+13.5%

Compare HTFL, SIBN, STIM, TMCI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗